Bone Marrow Transplant

Infusion of healthy blood stem cells into a patient after high-dose chemotherapy or radiation to restore bone marrow function in blood cancers like leukemia, lymphoma, and multiple myeloma.

Bone Marrow Transplant is recommended when non-surgical treatments have failed, when the condition significantly affects quality of life, or when imaging confirms the need for intervention. Your Oncology surgeon will assess your suitability after a detailed consultation.

Bone Marrow Transplant is typically performed under None (IV infusion) anesthesia. Your anaesthetist will review your health history, medications, and allergies before the procedure to ensure safety.

Most patients recover within 3–12 months, though this varies by individual health, age, and compliance with physiotherapy. Light activities can usually resume within a few weeks; full recovery takes longer.

As with any surgical procedure, risks include bleeding, infection, anaesthesia reactions, and rare complications such as injury to adjacent structures. Your surgeon will discuss your personal risk profile during the consent process.

Bone Marrow Transplant has a documented success rate of 70% when performed by qualified surgeons at accredited hospitals. Outcomes depend on the patient's overall health, disease severity, and adherence to post-operative care.